ABVC Biopharma-ABVC and Unit are eligible for license fees totaling $12.5 million in cash or Oncox Securities shares
ABVC Biopharma-ABVC和Unit有资格以现金或Oncox证券股份的形式获得总额为1,250万美元的许可费
ABVC Biopharma-ABVC and Unit are eligible for license fees totaling $12.5 million in cash or Oncox Securities shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.